Outcome measurements in scleroderma : Results from a delphi exerciseGAZI, Hashim; POPE, Janet E; EMERY, Paul et al.Journal of rheumatology. 2007, Vol 34, Num 3, pp 501-509, issn 0315-162X, 9 p.Article

Selective endothelin_A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue diseaseGIRGIS, Redo E; FROST, Adaani E; TAPSON, Victor F et al.Annals of the rheumatic diseases. 2007, Vol 66, Num 11, pp 1467-1472, issn 0003-4967, 6 p.Article

Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis results from the scleroderma lung studyKHANNA, Dinesh; CLEMENTS, Philip J; VARGA, John et al.Arthritis and rheumatism. 2005, Vol 52, Num 2, pp 592-600, issn 0004-3591, 9 p.Article

Effect of Oxidative Stress on Protein Tyrosine Phosphatase 1B in Scleroderma Dermal FibroblastsTSOU, Pei-Suen; TALIA, Nadine N; PINNEY, Adam J et al.Arthritis and rheumatism. 2012, Vol 64, Num 6, pp 1978-1989, issn 0004-3591, 12 p.Article

Minimally Important Differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract InstrumentKHANNA, Dinesh; FURST, Daniel E; MARANIAN, Paul et al.Journal of rheumatology. 2011, Vol 38, Num 9, pp 1920-1924, issn 0315-162X, 5 p.Article

High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis : long-term follow-up of the us multicenter pilot study. CommentaryVERRECCHIA, Franck; FARGE, Dominique; HENSTORF, Gretchen et al.Blood. 2007, Vol 110, Num 4, issn 0006-4971, 1088-1089, 1388-1396 [11 p.]Article

Bosentan in pulmonary arterial hypertension secondary to sclerodermaJOGLEKAR, Amit; TSAI, Fausan S; MCCLOSKEY, Deborah A et al.Journal of rheumatology. 2006, Vol 33, Num 1, pp 61-68, issn 0315-162X, 8 p.Article

Predictors and outcomes of scleroderma renal crisis: The high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trialDEMARCO, Paul J; WEISMAN, Michael H; MORELAND, Larry et al.Arthritis and rheumatism. 2002, Vol 46, Num 11, pp 2983-2989, issn 0004-3591, 7 p.Article

Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trialMATUCCI-CERINIC, Marco; DENTON, Christopher P; POPE, Janet E et al.Annals of the rheumatic diseases. 2011, Vol 70, Num 1, pp 32-38, issn 0003-4967, 7 p.Article

Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosisBODUKAM, Vijay; HAYS, Ron D; MARANIAN, Paul et al.Rheumatology (Oxford. Print). 2011, Vol 50, Num 2, pp 330-334, issn 1462-0324, 5 p.Article

Reliability and Validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract InstrumentKHANNA, Dinesh; HAYS, Ron D; FURST, Daniel E et al.Arthritis care and research. 2009, Vol 61, Num 9, pp 1257-1263, issn 0893-7524, 7 p.Article

Assessment of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis : Comparison of Noninvasive Tests with Results of Right-Heart CatheterizationHSU, Vivien M; MOREYRA, Abel E; WILSON, Alan C et al.Journal of rheumatology. 2008, Vol 35, Num 3, pp 458-465, issn 0315-162X, 8 p.Article

Validity, Reliability, and Feasibility of Durometer Measurements of Scleroderma Skin Disease in a Multicenter Treatment TrialMERKEL, Peter A; SILLIMAN, Nancy P; COPPOCK, John et al.Arthritis care and research. 2008, Vol 59, Num 5, pp 699-705, issn 0893-7524, 7 p.Article

The Disability Index of the health assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trialCLEMENTS, Philip J; WENG KEE WONG; MEDSGER, Thomas A et al.Arthritis and rheumatism. 2001, Vol 44, Num 3, pp 653-661, issn 0004-3591Article

Anti-Fibrillarin Antibody in African American Patients with Systemic Sclerosis: Immunogenetics, Clinical Features, and Survival AnalysisSHARIF, Roozbeh; FRITZLER, Marvin J; MOLITOR, Jerry A et al.Journal of rheumatology. 2011, Vol 38, Num 8, pp 1622-1630, issn 0315-162X, 9 p.Article

Developing Disease Activity and Response Criteria in Connective Tissue Disease-related Interstitial Lung DiseaseSAKETKOO, Lesley Ann; MATTESON, Eric L; BROWN, Kevin K et al.Journal of rheumatology. 2011, Vol 38, Num 7, pp 1514-1518, issn 0315-162X, 5 p.Article

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) databaseTYNDALL, Anthony J; BANNET, Bettina; IANNONE, Florenzo et al.Annals of the rheumatic diseases. 2010, Vol 69, Num 10, pp 1809-1815, issn 0003-4967, 7 p.Article

Validation of the 6 min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT groupAVOUAC, Jérôme; KOWAL-BIELECKA, Otylia; OPITZ, Christian F et al.Annals of the rheumatic diseases. 2010, Vol 69, Num 7, pp 1360-1363, issn 0003-4967, 4 p.Article

Randomized Placebo-Controlled Crossover Trial of Tadalafil in Raynaud's Phenomenon Secondary to Systemic SclerosisSCHIOPU, Elena; HSU, Vivien M; IMPENS, Ann J et al.Journal of rheumatology. 2009, Vol 36, Num 10, pp 2264-2268, issn 0315-162X, 5 p.Article

Sensitivity to change of the modified Rodnan skin score in diffuse systemic sclerosis―assessment of individual body sites in two large randomized controlled trialsKALDAS, Marian; KHANNA, Puja P; FURST, Daniel E et al.Rheumatology (Oxford. Print). 2009, Vol 48, Num 9, pp 1143-1146, issn 1462-0324, 4 p.Article

High-dose versus low-dose d-penicillamine in early diffuse systemic sclerosis trial: Lessons learnedCLEMENTS, Philip J; SEIBOLD, James R; STEEN, Virginia et al.Seminars in arthritis and rheumatism. 2004, Vol 33, Num 4, pp 249-263, issn 0049-0172, 15 p.Article

Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenonMERKEL, Peter A; HERLYN, Karen; ROTHFIELD, Naomi F et al.Arthritis and rheumatism. 2002, Vol 46, Num 9, pp 2410-2420, issn 0004-3591, 11 p.Article

Erectile dysfunction associated with scleroderma: A case-control study of men with scleroderma and rheumatoid arthritisHONG, Paul; POPE, Janet E; OUIMET, Janine M et al.Journal of rheumatology. 2004, Vol 31, Num 3, pp 508-513, issn 0315-162X, 6 p.Article

Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteriaJOHNSON, Sindhu R; NADEN, Raymond P; GABRIELLI, Armando et al.Journal of clinical epidemiology. 2014, Vol 67, Num 6, pp 706-714, issn 0895-4356, 9 p.Article

Clinical Course of Lung Physiology in Patients With Scleroderma and Interstitial Lung Disease: Analysis of the Scleroderma Lung Study Placebo GroupKHANNA, Dinesh; TSENG, Chi-Hong; SAGGAR, Rajeev et al.Arthritis and rheumatism. 2011, Vol 63, Num 10, pp 3078-3085, issn 0004-3591, 8 p.Article